The patent foramen ovale-migraine question

Neurological Sciences

Volumn 28, Issue SUPPL. 2, 2007, Pages

  Tepper, S J ^a,b   Sheftell, F D ^a,b,c   Bigal, M E ^a,d,e  

^a NEW ENGLAND CENTER FOR HEADACHE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e New England Institute for Behavioral Medicine   (United States)

Author keywords

Atrial septal defect; Migraine; Patent foramen ovale; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMIGRAINE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; OXYGEN;

ARTICLE; COMORBIDITY; DECOMPRESSION SICKNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; DIVING; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE INFARCTION; HEART SURGERY; HUMAN; HYPOXEMIA; LUNG ARTERIOVENOUS SHUNT; LUNG DISEASE; MIGRAINE WITH AURA; OXYGEN SATURATION; PATHOGENESIS; PREVALENCE; RENDU OSLER WEBER DISEASE; RISK ASSESSMENT; SHUNTING; STROKE;

CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; COMORBIDITY; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INTRACRANIAL EMBOLISM; LUNG; LUNG DISEASES; MIGRAINE DISORDERS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 34249288669     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-007-0763-7     Document Type: Article

References (34)

1. Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 59:17-20
2. Wilmhurst P, Bryson P (2000) Relationship between the clinical features of neurological decompression illness and its causes. Clin Sci 99:65-75
3. Del Sette M, Angeli S, Leandri M et al (1998) Migraine with aura and right-to-left shunt on transcranial Doppler: A casecontrol study. Cerebrovasc Dis 8:327-330
4. Anzola GP, Magoni M, Guindani M et al (1999) Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 52:1622-1625
5. Dowson A (2006) Presented at the American Academy of Neurology meeting, San Diego, CA
6. Lechat P, Mas JL, Lascault G et al (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318:1148-1152
7. Cabanes L, Mas JL, Cohen A et al (1993) Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24:1865-1873
8. Lamy C, Giannesini C, Zuber M et al (2002) Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 33:706-711
9. Sztajzel R, Genoud D, Roth S et al (2002) Patent foramen ovale, a possible cause of symptomatic migraine: A study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 13:102-106
10. Webster MW, Chancellor AM, Smith HJ et al (1988) Patent foramen ovale in young stroke patients. Lancet 2:11-12
11. Del Sette M, Angeli S, Leandri M et al (1998) Migraine with aura and right-to-left shunt on transcranial Doppler: A casecontrol study. Cerebrovasc Dis 8:327-330
12. Wilmshurst P, Nightingale S (2001) Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci 100:215-220
13. Wilmshurst P, Pearson M, Nightingale S (2005) Re-evaluation of the relationship between migraine and persistent foramen ovale and other right-to-left shunts. Clin Sci 108:365-367
14. Buring JE, Hebert P, Romero J et al (1995) Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 52:129-134
15. Carolei A, Marini C, De Matteis G (1996) History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 347:1503-1506
16. De Castro S, Cartoni D, Fiorelli M et al (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31:2407-2413
17. Milhaud D, Bogousslavsky J, van Melle G, Liot P (2001) Ischemic stroke and active migraine. Neurology 57:1805-1811
18. Kruit MC, van Buchem MA, Hofman PA et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427-434
19. Morandi E, Anzola GP, Angeli S et al (2003) Transcatheter closure of patent foramen ovale: A new migraine treatment? J Interv Cardiol 16:39-42
20. Post MC, Thijs V, Herroelen L, Budts WI (2004) Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 62:1439-1440
21. Schwerzmann M, Wiher S, Nedeltchev K et al (2004) Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62:1399-1401
22. Azarbal B, Tobis J, Suh W et al (2005) Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 45:489-492
23. Reisman M, Christofferson RD, Jesurum J et al (2005) Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45:493-495
24. Anzola GP, Frisoni GB, Morandi E et al (2006) Shunt-associated migraine responds favorably to atrial septal repair: A casecontrol study. Stroke 37:430-434
25. Steele JG, Nath PU, Burn J, Porteous ME (1993) An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 33:145-148
26. Thenganatt J, Schneiderman J, Hyland RH et al (2006) Migraines linked to intrapulmonary right-to-left shunt. Headache 46:439-443
27. Kruit MC, van Buchem MA, Hofman PA et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427-434
28. Wilmshurst PT, Nightingale S,Walsh KP,Morrison WL (2005) Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 91:1173-1175
29. Dowson A (2006) Platform presentation at the American Academy of Neurology Meeting, San Diego, CA, April
30. Mathew NT, Rapoport A, Saper J et al (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41:119-128
31. Brandes JL, Saper JR, Diamond M et al and the MIGR-002 Study Group (2004) Topiramate for migraine prevention: A randomized controlled trial. JAMA 291:965-973
32. Klapper J (1997) Divalproex sodium in migraine prophylaxis: A dose-controlled study. Cephalalgia 17:103-108
33. Silberstein SD, Neto W, Schmitt J, Jacobs D, and the MIGR-001 Study Group (2004) Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 61:490-495
34. Diener HC, Tfelt-Hansen P, Dahlof C et al and the MIGR-003 Study Group (2004) Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 251:943-950